|
1
|
Venerito M, Link A, Rokkas T and Malfertheiner P: Review: Gastric cancer-clinical aspects. Helicobacter. 24 (Suppl 1):e126432019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Machlowska J, Baj J, Sitarz M, Maciejewski R and Sitarz R: Gastric cancer: Epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 21:40122020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rawla P and Barsouk A: Epidemiology of gastric cancer: Global trends, risk factors and prevention. Prz Gastroenterol. 14:26–38. 2019.PubMed/NCBI
|
|
4
|
Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand. 64:31–49. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Waldum HL and Fossmark R: Types of gastric carcinomas. Int J Mol Sci. 19:41092018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yakirevich E and Resnick MB: Pathology of gastric cancer and its precursor lesions. Gastroenterol Clin North Am. 42:261–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yuasa Y: Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer. 3:592–600. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Garcia-Pelaez J, Barbosa-Matos R, Gullo I, Carneiro F and Oliveira C: Histological and mutational profile of diffuse gastric cancer: Current knowledge and future challenges. Mol Oncol. Mar 16–2021.(Online ahead of print). View Article : Google Scholar
|
|
9
|
Ansari S, Gantuya B, Tuan VP and Yamaoka Y: Diffuse gastric cancer: A summary of analogous contributing factors for its molecular pathogenicity. Int J Mol Sci. 19:24242018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsai JH, Jeng YM, Chen KH, Lee CH, Yuan CT and Liau JY: An integrative morphomolecular classification system of gastric carcinoma with distinct clinical outcomes. Am J Surg Pathol. 44:1017–1030. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lim B, Kim JH, Kim M and Kim SY: Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer. World J Gastroenterol. 22:1190–1201. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tan IB, Ivanova T, Lim KH, Ong CW, Deng N, Lee J, Tan SH, Wu J, Lee MH, Ooi CH, et al: Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology. 141:476–485.e1-11. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Petrovchich I and Ford JM: Genetic predisposition to gastric cancer. Semin Oncol. 43:554–559. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shenoy S: CDH1 (E-cadherin) mutation and gastric cancer: Genetics, molecular mechanisms and guidelines for management. Cancer Manag Res. 11:10477–10486. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F and Sobrinho-Simöes M: E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene. 20:1525–1528. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tedaldi G, Molinari C, São José C, Barbosa-Matos R, André A, Danesi R, Arcangeli V, Ravegnani M, Saragoni L, Morgagni P, et al: Genetic and epigenetic alterations of CDH1 regulatory regions in hereditary and sporadic gastric cancer. Pharmaceuticals (Basel). 14:4572021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gamble LA, Heller T and Davis JL: Hereditary diffuse gastric cancer syndrome and the role of CDH1: A review. JAMA Surg. 156:387–392. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cho SY, Park JW, Liu Y, Park YS, Kim JH, Yang H, Um H, Ko WR, Lee BI, Kwon SY, et al: Sporadic early-onset diffuse gastric cancers have high frequency of somatic CDH1 alterations, but low frequency of somatic RHOA mutations compared with late-onset cancers. Gastroenterology. 153:536–549.e26. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kakiuchi M, Nishizawa T, Ueda H, Gotoh K, Tanaka A, Hayashi A, Yamamoto S, Tatsuno K, Katoh H, Watanabe Y, et al: Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma. Nat Genet. 46:583–587. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou J, Hayakawa Y, Wang TC and Bass AJ: RhoA mutations identified in diffuse gastric cancer. Cancer Cell. 26:9–11. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nam S, Kim JH and Lee DH: RHOA in gastric cancer: Functional roles and therapeutic potential. Front Genet. 10:4382019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
MacDonald BT, Tamai K and He X: Wnt/beta-catenin signaling: Components, mechanisms, and diseases. Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tian X, Liu Z, Niu B, Zhang J, Tan TK, Lee SR, Zhao Y, Harris DC and Zheng G: E-cadherin/β-catenin complex and the epithelial barrier. J Biomed Biotechnol. 2011:5673052011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu X and Chu KM: E-cadherin and gastric cancer: Cause, consequence, and applications. Biomed Res Int. 2014:6373082014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Korourian A, Roudi R, Shariftabrizi A, Kalantari E, Sotoodeh K and Madjd Z: Differential role of Wnt signaling and base excision repair pathways in gastric adenocarcinoma aggressiveness. Clin Exp Med. 17:505–517. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Reya T and Clevers H: Wnt signalling in stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Y and Wang X: Targeting the Wnt/β-catenin signaling pathway in cancer. J Hematol Oncol. 13:1652020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Krausova M and Korinek V: Wnt signaling in adult intestinal stem cells and cancer. Cell Signal. 26:570–579. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Koushyar S, Powell AG, Vincan E and Phesse TJ: Targeting Wnt signaling for the treatment of gastric cancer. Int J Mol Sci. 21:39272020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ooi CH, Ivanova T, Wu J, Lee M, Tan IB, Tao J, Ward L, Koo JH, Gopalakrishnan V, Zhu Y, et al: Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet. 5:e10006762009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yoda Y, Takeshima H, Niwa T, Kim JG, Ando T, Kushima R, Sugiyama T, Katai H, Noshiro H and Ushijima T: Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer. Gastric Cancer. 18:65–76. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chiurillo MA: Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review. World J Exp Med. 5:84–102. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nojima M, Suzuki H, Toyota M, Watanabe Y, Maruyama R, Sasaki S, Sasaki Y, Mita H, Nishikawa N, Yamaguchi K, et al: Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Oncogene. 26:4699–4713. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cheng YY, Yu J, Wong YP, Man EP, To KF, Jin VX, Li J, Tao Q, Sung JJ, Chan FK and Leung WK: Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. Br J Cancer. 97:895–901. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shin H, Kim JH, Lee YS and Lee YC: Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: Induction of promoter demethylation and histone modification causing inhibition of Wnt signaling. Int J Oncol. 40:1533–1542. 2012.PubMed/NCBI
|
|
36
|
Liu JB, Wu XM, Cai J, Zhang JY, Zhang JL, Zhou SH, Shi MX and Qiang FL: CpG island methylator phenotype and Helicobacter pylori infection associated with gastric cancer. World J Gastroenterol. 18:5129–5134. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
To KF, Chan MW, Leung WK, Yu J, Tong JH, Lee TL, Chan FK and Sung JJ: Alterations of frizzled (FzE3) and secreted frizzled related protein (hsFRP) expression in gastric cancer. Life Sci. 70:483–489. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Guo Y, Guo W, Chen Z, Kuang G, Yang Z and Dong Z: Hypermethylation and aberrant expression of Wnt-antagonist family genes in gastric cardia adenocarcinoma. Neoplasma. 58:110–117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang Z, Ye Y, Liu D, Yang X and Wang F: Hypermethylation of multiple Wnt antagonist genes in gastric neoplasia: Is H pylori infection blasting fuse? Medicine (Baltimore). 97:e137342018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nagasaka T, Tanaka N, Cullings HM, Sun DS, Sasamoto H, Uchida T, Koi M, Nishida N, Naomoto Y, Boland CR, et al: Analysis of fecal DNA methylation to detect gastrointestinal neoplasia. J Natl Cancer Ins. 101:1244–1258. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao C, Bu X, Zhang N and Wang W: Downregulation of SFRP5 expression and its inverse correlation with those of MMP-7 and MT1-MMP in gastric cancer. BMC Cancer. 9:2242009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu C, Li N, Lu H, Wang Z, Chen C, Wu L, Liu J, Lu Y and Wang F: Circulating SFRP1 promoter methylation status in gastric adenocarcinoma and esophageal square cell carcinoma. Biomed Rep. 3:123–127. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yu J, Xie Y, Li M, Zhou F, Zhong Z, Liu Y, Wang F and Qi J: Association between SFRP promoter hypermethylation and different types of cancer: A systematic review and meta-analysis. Oncol Lett. 18:3481–3492. 2019.PubMed/NCBI
|
|
44
|
Kim SK, Kim HJ, Park JL, Heo H, Kim SY, Lee SI, Song KS, Kim WH and Kim YS: Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer. Gastric Cancer. 23:473–482. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu D, Sun C, Kim N, Bhan C, Tuason JPW, Chen Y, Ma S, Huang Y, Cheng C, Zhou Q, et al: Comprehensive analysis of SFRP family members prognostic value and immune infiltration in gastric cancer. Life (Basel). 11:5222021.PubMed/NCBI
|
|
46
|
Baharudin R, Tieng FYF, Lee LH and Ab Mutalib NS: Epigenetics of SFRP1: The dual roles in human cancers. Cancers (Basel). 12:4452020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gao C and Chen YG: Dishevelled: The hub of Wnt signaling. Cell Signal. 22:717–727. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Katoh M: WNT/PCP signaling pathway and human cancer (review). Oncol Rep. 14:1583–1588. 2005.PubMed/NCBI
|
|
49
|
Liu Y, Zhang J, Yu W, Zhang X, Wang G and Zhao Z: Dapper homolog 1 alpha suppresses metastasis ability of gastric cancer through inhibiting planar cell polarity pathway. Oncotarget. 7:81423–81434. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gnad T, Feoktistova M, Leverkus M, Lendeckel U and Naumann M: Helicobacter pylori-induced activation of beta-catenin involves low density lipoprotein receptor-related protein 6 and Dishevelled. Mol Cancer. 9:312010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bosman FT: WHO classification of tumours of the digestive system. World Health Organization classification of tumours. Bosman FT, Carneiro F, Hruban R H and Theise N: 4th edition. IARC Press; Lyon: 2010
|
|
52
|
Sadeghipour A and Babaheidarian P: Making formalin-fixed, paraffin embedded blocks. Methods Mol Biol. 1897:253–268. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Nikuševa-Martić T, Serman L, Zeljko M, Vidas Z, Gašparov S, Zeljko HM, Kosović M and Pećina-Šlaus N: Expression of secreted frizzled-related protein 1 and 3, T-cell factor 1 and lymphoid enhancer factor 1 in clear cell renal cell carcinoma. Pathol Oncol Res. 19:545–551. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Partl JZ, Fabijanovic D, Skrtic A, Vranic S, Martic TN and Serman L: Immunohistochemical expression of SFRP1 and SFRP3 proteins in normal and malignant reproductive tissues of rats and humans. Appl Immunohistochem Mol Morphol. 22:681–687. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Weibel ER: Stereological methods. 1. practical methods for biological morphometry. Academic press; London: pp. 1–415. 1979
|
|
56
|
Wicksell SD: The corpuscle problem A mathematical study of a biometric problem. Biometrika. 17:84–99. 1925. View Article : Google Scholar
|
|
57
|
Wicksell SD: The corpuscle problem Second memoir case of ellipsoidal corpuscles. Biometrika. 18:151–172. 1926. View Article : Google Scholar
|
|
58
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Goldman MJ, Craft B, Hastie M, Repečka K, McDade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN, et al: Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 38:675–678. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and Varambally S: UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 19:649–658. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Aran D, Camarda R, Odegaard J, Paik H, Oskotsky B, Krings G, Goga A, Sirota M and Butte AJ: Comprehensive analysis of normal adjacent to tumor transcriptomes. Nat Commun. 8:10772017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zeng WZD, Glicksberg BS, Li Y and Chen B: Selecting precise reference normal tissue samples for cancer research using a deep learning approach. BMC Med Genomics. 12 (Suppl 1):S212019. View Article : Google Scholar
|
|
63
|
GTEx Consortium: The genotype-tissue expression (GTEx) project. Nat Genet. 45:580–585. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Ming SC: Gastric carcinoma. A pathobiological classification. Cancer. 39:2475–2485. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Nakamura K, Sugano H and Takagi K: Carcinoma of the stomach in incipient phase: Its histogenesis and histological appearances. Gan. 59:251–258. 1968.PubMed/NCBI
|
|
66
|
Patel MI, Rhoads KF, Ma Y, Ford JM, Visser BC, Kunz PL, Fisher GA, Chang DT, Koong A, Norton JA and Poultsides GA: Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: Is there room for improvement? Ann Surg Oncol. 20:1631–1638. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhao CH, Bu XM and Zhang N: Hypermethylation and aberrant expression of Wnt antagonist secreted frizzled-related protein 1 in gastric cancer. World J Gastroenterol. 13:2214–2217. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zhang T, Wu Y, Fang Z, Yan Q, Zhang S, Sun R, Khaliq J and Li Y: Low expression of RBMS3 and SFRP1 are associated with poor prognosis in patients with gastric cancer. Am J Cancer Res. 6:2679–2689. 2016.PubMed/NCBI
|
|
69
|
Kinoshita T, Nomoto S, Kodera Y, Koike M, Fujiwara M and Nakao A: Decreased expression and aberrant hypermethylation of the SFRP genes in human gastric cancer. Hepatogastroenterology. 58:1051–1056. 2011.PubMed/NCBIPubMed/NCBI
|
|
70
|
Katoh Y and Katoh M: WNT antagonist, SFRP1, is Hedgehog signaling target. Int J Mol Med. 17:171–175. 2006.PubMed/NCBI
|
|
71
|
Katoh M and Katoh M: Integrative genomic analyses of ZEB2: Transcriptional regulation of ZEB2 based on SMADs, ETS1, HIF1alpha, POU/OCT, and NF-kappaB. Int J Oncol. 34:1737–1742. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Kim JH, Shin HS, Lee SH, Lee I, Lee YS, Park JC, Kim YJ, Chung JB and Lee YC: Contrasting activity of Hedgehog and Wnt pathways according to gastric cancer cell differentiation: Relevance of crosstalk mechanisms. Cancer Sci. 101:328–335. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Peng JX, Liang SY and Li L: sFRP1 exerts effects on gastric cancer cells through GSK3β/Rac1-mediated restraint of TGFβ/Smad3 signaling. Oncol Rep. 41:224–234. 2019.PubMed/NCBI
|
|
74
|
Yang HJ, Kim SG, Lim JH, Choi JM, Kim WH and Jung HC: Helicobacter pylori-induced modulation of the promoter methylation of Wnt antagonist genes in gastric carcinogenesis. Gastric Cancer. 21:237–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Wu F, Li J, Guo N, Wang XH and Liao YQ: MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting SFRP1 via Wnt/β-catenin signaling pathway. Am J Cancer Res. 7:405–416. 2017.PubMed/NCBI
|
|
76
|
Feng C, She J, Chen X, Zhang Q, Zhang X, Wang Y, Ye J, Shi J, Tao J, Feng M, et al: Exosomal miR-196a-1 promotes gastric cancer cell invasion and metastasis by targeting SFRP1. Nanomedicine (Lond). 14:2579–2593. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Ouyang J, Xie Z, Lei X, Tang G, Gan R and Yang X: Clinical crosstalk between microRNAs and gastric cancer (Review). Int J Oncol. 58:72021. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Xu C, Cheng H, Li N, Zhou N and Tang X: Relationship between microRNA-27a and efficacy of neoadjuvant chemotherapy in gastric cancer and its mechanism in gastric cancer cell growth and metastasis. Biosci Rep. 39:BSR201811752019. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Ren J, Huang HJ, Gong Y, Yue S, Tang LM and Cheng SY: MicroRNA-206 suppresses gastric cancer cell growth and metastasis. Cell Biosci. 4:262014. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Alessandrini L, Manchi M, De Re V, Dolcetti R and Canzonieri V: Proposed molecular and miRNA classification of gastric cancer. Int J Mol Sc. 19:16832018. View Article : Google Scholar
|
|
81
|
Qu Y, Ray PS, Li J, Cai Q, Bagaria SP, Moran C, Sim MS, Zhang J, Turner RR, Zhu Z, et al: High levels of secreted frizzled-related protein 1 correlate with poor prognosis and promote tumourigenesis in gastric cancer. Eur J Cancer. 49:3718–3728. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Cui HB, Ge HE, Wang YS and Bai XY: miR-208a enhances cell proliferation and invasion of gastric cancer by targeting SFRP1 and negatively regulating MEG3. Int J Biochem Cell Biol. 102:31–39. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Peng JX, Liang SY and Li L: sFRP1 exerts effects on gastric cancer cells through GSK3β/Rac1-mediated restraint of TGFβ/Smad3 signaling. Oncol Rep. 41:224–234. 2019.PubMed/NCBI
|
|
84
|
Surana R, Sikka S, Cai W, Shin EM, Warrier SR, Tan HJ, Arfuso F, Fox SA, Dharmarajan AM and Kumar AP: Secreted frizzled related proteins: Implications in cancers. Biochim Biophys Acta. 1845:53–65. 2014.PubMed/NCBI
|
|
85
|
Lin K, Wang S, Julius MA, Kitajewski J, Moos M Jr and Luyten FP: The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling. Proc Natl Acad Sci USA. 94:11196–11200. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Qu Y, Li JF, Cai Q, Wang YW, Gu QL, Zhu ZG and Liu BY: Over-expression of FRZB in gastric cancer cell suppresses proliferation and induces differentiation. J Cancer Res Clin Oncol. 134:353–364. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Byun T, Karimi M, Marsh JL, Milovanovic T, Lin F and Holcombe RF: Expression of secreted Wnt antagonists in gastrointestinal tissues: Potential role in stem cell homeostasis. J Clin Pathol. 58:515–519. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Qin S, Zhang Z, Li J and Zang L: FRZB knockdown upregulates β-catenin activity and enhances cell aggressiveness in gastric cancer. Oncol Rep. 31:2351–2357. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Uematsu K, He B, You L, Xu Z, McCormick F and Jablons DM: Activation of the Wnt pathway in non small cell lung cancer: Evidence of dishevelled overexpression. Oncogene. 22:7218–7221. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Sareddy GR, Panigrahi M, Challa S, Mahadevan A and Babu PP: Activation of Wnt/β-catenin/Tcf signaling pathway in human astrocytomas. Neurochem Int. 55:307–317. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
You XJ, Bryant PJ, Jurnak F and Holcombe RF: Expression of Wnt pathway components frizzled and disheveled in colon cancer arising in patients with inflammatory bowel disease. Oncol Rep. 18:691–694. 2007.PubMed/NCBI
|
|
92
|
Hegazy SA, Alshareef A, Gelebart P, Anand M, Armanious H, Ingham RJ, Ingham RJ and Lai R: Disheveled proteins promote cell growth and tumorigenicity in ALK-positive anaplastic large cell lymphoma. Cell Signal. 25:295–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Kafka A, Karin-Kujundžić V, Šerman L, Bukovac A, Njirić N, Jakovčević A and Pećina-Šlaus N: Hypermethylation of secreted frizzled related protein 1 gene promoter in different astrocytoma grades. Croat Med J. 59:213–223. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Astudillo P: Wnt5a signaling in gastric cancer. Front Cell Dev Biol. 8:1102020. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Ara H, Takagishi M, Enomoto A, Asai M, Ushida K, Asai N, Shimoyama Y, Kaibuchi K, Kodera Y and Takahashi M: Role for Daple in non-canonical Wnt signaling during gastric cancer invasion and metastasis. Cancer Sci. 107:133–139. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Peng Q, Chen L, Wu W, Wang J, Zheng X, Chen Z, Jiang Q, Han J, Wei L, Wang L, et al: EPH receptor A2 governs a feedback loop that activates Wnt/β-catenin signaling in gastric cancer. Cell Death Dis. 9:11462018. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Gao J, Zhao C, Liu Q, Hou X, Li S, Xing X, Yang C and Luo Y: Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1. J Exp Clin Cancer Res. 37:3172018. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Peng Y and Wang HH: Cir-ITCH inhibits gastric cancer migration, invasion and proliferation by regulating the Wnt/β-catenin pathway. Sci Rep. 101:174432020. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Deng YZ, Yao F, Li JJ, Mao ZF, Hu PT, Long LY, Li G, Ji XD, Shi S, Guan DX, et al: RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex. Gastroenterology. 142:812–823.e15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Demirci U, Örenay Boyacıoğlu S, Kasap E, Bilgiç F, Gerçeker E, Yıldırım H, Baykan A, Ellidokuz E, Yüceyar M and Korkmaz M: P-014 are RHOA, CSNK1A1, DVL2, FZD8 and LRP5 genes novel biomarkers in the conversion from intestinal metaplasia to gastric Cancer? Ann Oncol. 27 (Suppl 2):ii42016. View Article : Google Scholar
|
|
101
|
Chong Y, Mia-Jan K, Ryu H, Abdul-Ghafar J, Munkhdelger J, Lkhagvadorj S, Jung SY, Lee M, Ji SY, Choi E and Cho MY: DNA methylation status of a distinctively different subset of genes is associated with each histologic Lauren classification subtype in early gastric carcinogenesis. Oncol Rep. 31:2535–2544. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Cancer Genome Atlas Research Network, . Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, et al: Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2:449–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Katona BW and Rustgi AK: Gastric cancer genomics: Advances and future directions. Cell Mol Gastroenterol Hepatol. 3:211–217. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Oh SC, Sohn BH, Cheong JH, Kim SB, Lee JE, Park KC, Lee SH, Park JL, Park YY, Lee HS, et al: Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype. Nat Commun. 9:17772018. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Carino A, Graziosi L, Marchianò S, Biagioli M, Marino E, Sepe V, Zampella E, Distrutti E, Donini A and Fiorucci S: Analysis of gastric cancer transcriptome allows the identification of histotype specific molecular signatures with prognostic potential. Front Oncol. 11:6637712021. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Sexton RE, Hallak MNA, Uddin MH, Diab M and Azmi AS: Gastric cancer heterogeneity and clinical outcomes. Technol Cancer Res Treat. 19:15330338209354772020. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Li L and Wang X: Identification of gastric cancer subtypes based on pathway clustering. NPJ Precis Oncol. 5:462021. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Wong SS, Kim KM, Ting JC, Yu K, Fu J, Liu S, Cristescu R, Nebozhyn M, Gong L, Yue YG, et al: Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing. Nat Commun. 5:54772014. View Article : Google Scholar : PubMed/NCBI
|
